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ABSTRACT OF THE THESIS 
APTAMER-BASED ASSAY FOR DETECTION OF OCHRATOXIN A 
by 
Amanda Nicole Bartley 
Florida International University, 2018 
Miami, Florida 
Professor John P. Berry, Major Professor 
Ochratoxin A (OTA) is a potent mycotoxin found in a wide range of agricultural products 
that has been linked to mitochondrial damage and renal disease. The standard methods 
for OTA analysis currently rely on the use of high-performance liquid chromatography 
(HPLC) coupled to fluorescence detection or mass spectrometry. Toward a high-
throughput analysis of OTA, a single-stranded DNA aptamer, modified with a 
fluorophore, coupled to a complementary sequence, modified with a FRET-based 
quencher that dissociates in the presence of the target toxin, is proposed.  In order to 
integrate target trapping, aptamer immobilization methods were explored to mediate 
interference issues.  Assays were evaluated using wine and blood serum matrices.  A 
solution-based assay in a 96-well plate format provided a limit-of-detection of 2.7 ng/mL 
which would be suitable for many of the proposed applications.  Immobilized aptamer 
formats, however, were not reliable, and a range of limitations to applications of the 
assay were identified. 
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CHAPTER 1: INTRODUCTION 
 
 Ochratoxin A (OTA) is a fungal mycotoxin that is produced as a secondary 
metabolite of fungi belonging to the genera Aspergillus and Penicillium (1). Ochratoxin 
A was first discovered by Vanderme et al., in 1965 (2). Structurally, OTA is 
phenylalanine bound to a dihydroisocoumarin moiety through an amide bond (Figure 1). 
 
Figure 1: Chemical structure of Ochratoxin A 
Ochratoxin A is one of the most common mycotoxins found as an agricultural 
contaminant of fruits and grains, and products of these (e.g., bread, beer, and wine). 
Ochratoxin A is absorbed into the gastrointestinal tract and binds to plasma proteins. It is 
excreted from the body with a half-life of about 35 days (1). Toxicologically, OTA is 
hepatoxic, nephrotoxic, and mutagenic to mammals (3), and shown to have inhibitory 
effects on several enzymes that use phenylalanine as a substrate (4), as well as to cause 
mitochondrial damage. Epidemiologically, OTA has been linked to the Balkan Endemic 
Nephropathy (BEN) renal disease (5). Linked to renal cancer, the International Agency 
for Research on Cancer (IARC) has classified OTA as Group 2B, or a possible human 
carcinogen (1) (5). However, there are few nations that have set regulatory standards to 
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limit OTA presence in foodstuffs, such as Brazil, Israel, Switzerland, Uruguay, and the 
European Union (1). 
 Wine is of a growing concern among agricultural products, shown to be 
contaminated with OTA, because of increased consumption worldwide. Factors which 
drive the occurrence of OTA in wine remain to be fully understood. The two most 
common species of fungi found in grapes and wine are A. niger and A. carbonarius. It 
was founded that these OTA producing fungi grow well under a wide pH range, 5.0-6.5, 
and were influenced by water availability (6). Higher concentration and contamination 
levels of OTA in red wines than white wines, from the same growing region, have been 
reported and suggested to be related to wine making techniques: production of red wine 
requires a mash (“must”) to be produced that includes the skin and pulp of grapes, while 
white wines discard the skin, potentially increasing exposure to OTA (in skins) during the 
fermentation process (7). Furthermore, climate was found to have possible effects on the 
production of OTA: southern climates with dry, hot summers had an increased presence 
(7). The European Union (EU) has established regulatory limits on OTA for wine, and 
the EU regulatory limits prohibit levels above two parts-per-billion (2 ng/mL). 
Additionally, the presence of OTA in human serum has been related to the 
consumption of contaminated foods. Ochratoxin A binds to albumin with an unusually 
high affinity, resulting in 99.5% of OTA in the circulatory system (8). Lino et al. (2008) 
conducted a study of three areas in Portugal, collecting 104 serum samples, identifying 
OTA concentrations between 0.14 and 2.49 µg/L based on the consumption of a variety 
of contaminated goods (9). Furthermore, a correlation between certain medical issues, 
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such as the Balkan Endemic Nephropathy and urinary system tumors, have been related 
to an increase presence of OTA in foodstuffs and in serum levels. It was founded that 
several factors affect plasma concentrations of OTA including person to person variation, 
region variability, and seasonality (10). 
The biosynthetic pathways of OTA have not been fully characterized and are 
currently being investigated. Polyketide Synthase (PKS) and Non-Ribosomal Peptide 
Synthetase (NRPS) are multimodular enzymes involved in the biosynthesis of many 
secondary metabolites. The dihydroisocoumarin moiety of OTA (Figure 1) is believed to 
be catalyzed by PKS. The dihydroisocoumarin is linked to L-phenylalanine via amide 
bond, which is catalyzed by NRPS (11). Polyketides and non-ribosomal peptides are, in 
fact, linked to many mycotoxins.  
 
Analytical Methods for OTA 
 
 A variety of analytical methods have been explored for quantitative analysis of 
OTA in various foodstuffs. The most common methods currently include enzyme-linked 
immunoassays (ELISA), and methods based on high-performance liquid chromatography 
coupled to either fluorescence detection (HPLC-FD) or mass spectrometry (HPLC-MS). 
However, these methods often require extensive extraction and/or sample clean-up steps.  
ELISA for OTA 
 
 There are multiple ELISA formats that have been used to detect OTA, the most 
common being a “sandwich style” format.  Detection in ELISA results from the 
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interaction between antibodies and antigens specific to the target, (e.g., OTA) (12). In the 
sandwich format, antigens representing the target (i.e., OTA) are immobilized to the 
bottom surface of multiwell (e.g., 96-well) plates, and with the addition of an OTA-
specific antibody, form a complex. Subsequently, a second antibody that is bound to a 
“reporter” (typically colorimetric, e.g., horseradish peroxidase) enzyme is added, and free 
OTA added to the well competes, in turn, with the antigen for the enzyme conjugate. 
Upon addition of the colorimetric enzyme substrate, a color change results, and OTA can 
be quantitated as an inverse relationship between concentration and color signal (13).  
Although ELISA kits for OTA are commercially available, they can be relatively 
expensive, and accuracy of the technique has frequently been suggested to be rather low. 
Limits of detection for OTA by way of ELISA methods tend to be around 0.2 ng/mL, 
fairly close to HPLC-FD methods. However, inter-assay coefficient of variation can 
range from 4.78-16.67%. Additionally, it has been shown that there are several food 
matrix effects that can interfere with ELISA, by way of non-specific interactions or cross 
reactivity (14). Using wine as a sample matrix has, indeed, led to mixed results as there 
are interfering species in wine, particularly including a range of phenolics, which may 
interfere with antibody-binding (15). The addition of polyvinylpyrollidone (PVP) has, 
therefore, been used for removing polyphenols, and reducing interferences (i.e., “false 
positives”) in immunoassays (15).  
HPLC-FD and HPLC-MS of OTA 
High-Performance Liquid Chromatography (HPLC) enables analytical separation 
of OTA from other components of sample matrices, and therefore, can increase 
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selectivity and reliability. When coupled to fluorescence detection, HPLC-FD has shown 
sensitive detection and quantitation of OTA in foodstuffs as low as 0.01-0.30 µg/kg 
depending on sample matrices (16).  In a recent study, a simplified liquid/liquid 
extraction (LLE) method – eliminating more extensive sample preparation and clean-up 
steps - was developed and applied to HPLC-FD detection OTA in wine, De Jesus et al. 
(2018).  In this method, De Jesus et al. (2018) used simple extraction with chloroform 
(followed by concentration in vacuo) which was found to be sufficient for recovery of 
OTA, and subsequent HPLC-FD.  The method achieved LOD and LOQ of 0.1 and 0.3 
µg/L, respectively, and was applied to 41 wine samples sourced from the United States, 
showing that more than 85% (of the 41 wines tested) were above the LOD (0.1 µg/L), 
and 31 of these OTA-positive wines were above the LOQ (0.3 µg/L) (17). The sensitivity 
of this simple LLE is, therefore, well below the EU’s regulatory limit of 2 ng/mL in wine, 
and can be classified as “quick, easy, cheap, effective, rugged, and safe” (QuEChERS). 
High-Performance Liquid Chromatography coupled to Mass Spectrometry 
(HPLC-MS) has been used as a confirmatory method for the detection of OTA and, in 
fact, multi-mycotoxin analysis in foodstuffs (18).  Typically, 13C-labeled internal 
standards are used to compensate for matrix effects when identifying and quantifying 
mycotoxins by this technique. As an example of using 13C-labeled internal standards, Al-
Taher et al. (2013) surveyed 143 red and white wines from 4 major growing regions by 
means of a simple dilution of wine (and beer) at a 1:5 ratio, and subsequently injected 
into the UHPLC-MS/MS system for multi-mycotoxin analysis (19). It was founded that 
OTA, among other mycotoxins, were affected by ion enhancement with spiked white 
wine samples. The methodology applied in this study shows that the LOD and LOQ 
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values for both red and white wine were 0.1 and 0.5 ng/mL, respectively, and are well 
below the EU’s regulatory limit of 2 ng/mL (19). 
 
Aptamer-Based Analysis for OTA 
An increasing number of studies have utilized aptamers for detection of OTA and 
a wide range of analytical applications. Aptamers derive from the Latin word aptus, “to 
fit”, and are typically single or double stranded oligonucleotides. Aptamers bind to a 
specified target molecule and are more chemically stable and cost effective than 
antibody-based (i.e. ELISA) methods. Aptamers are created through a process known as 
SELEX, or Systematic Evolution of Ligands by Exponential Enrichment (20). An 
aptamer sequence, specific for OTA, was previously identified by Cruz-Aguado et al. 
(2008) by way of SELEX. The aptamer sequence is 5′-GAT CGG GTG TGG GTG GCG 
TAA AGG GAG CAT CGG ACA-3’ (21). Most analytical methods employing aptamers 
for OTA detection and quantitation utilize this aptamer sequence with few modifications. 
Gold Nanoparticles  
 Assays for OTA detection and quantitation using aptamers bound to gold 
nanoparticles (AuNPs) have been previously developed (22) (23) (24). Gold 
nanoparticles are colorimetric indicators whose size and dispersion changes in the 
presence of salt, resulting in a measurable color shift from red to blue. In assays, target-
specific aptamers are bound to the surface of an AuNPs, and in the presence of OTA, a 
structural change occurs revealing the AuNP’s surface, allowing interactions with salts, 
and therefore, the corresponding quantifiable color change (2). As an example, a study 
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conducted by Luan et al. (2015) developed an assay using AuNP’s and a cationic 
polymer, polydiallyldimethylammonium chloride (PDDA) to colorimetrically detect 
OTA in Chinese distilled liquor. In this assay, the OTA aptamer is free to form a duplex 
with PDDA in the absence of OTA, and therefore, no color change will occur. However, 
when OTA is present, the aptamer forms a “G-quadruplex” structure, and PDDA 
aggregates the AuNP’s. The reported linear concentration range for this assay is 0.05-
50ng/mL with an LOD of 0.009ng/mL (23). 
Direct Detection of OTA by Aptamers in Solution 
Assays that use the direct interaction between OTA and aptamers in solution was 
recently developed by Chen et al. (2012). The assay specifically utilizes a so-called 
“structure switching,” aptamer formation in which a signaling aptamer specific for OTA, 
bound to a fluorophore (i.e., fluorescein, or FAM) is paired with a quencher (i.e., 
TAMRA) modified complementary sequence. Upon addition of OTA, a conformational 
structure change occurs, therefore, displacing the complementary quencher sequence, and 
enabling emission of the fluorescent signal (Figure 2) (25).  
The basic premise of the assay is as follows: two DNA oligomer sequences - the 
aptamer and complementary “quencher” strand - form a duplex (following heating and 
cooling). Through a FRET-based mechanism, the quencher strand (via TAMRA 
modification) attenuates the emission of fluorophore (i.e., FAM) on the aptamer 
sequence, thus resulting in a very low level of base fluorescence. Aptamers, in turn, have 
the ability to form a complex with the target (i.e., OTA) allowing a conformation change. 
Specifically, upon addition of the target OTA, the fluorophore-modified aptamer strand 
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forms the complex with the target, and releases the quencher strand (Figure 2) enabling a 
measurable increase in fluorescent emission. 
 
Figure 2: Depiction of conformation change of aptamers with addition of OTA. 
 Chen et al. (2012) indicated that the fluorescent signal is linear from the range 1 
to 100 ng/mL with a reported limit of detection (LOD) of 0.8 ng/mL. The repeatability of 
the assay, using the relative standard deviation (RSD), was reported as 2.4% and 
reproducibility (reported an RSD of eight separate samples with the same concentration) 
was 4.7%. Selectivity was measured by adding other mycotoxins, including aflatoxin B1 
and zearalenone, and the structurally related ochratoxin B (OTB), into the mixture, and 
measuring fluorescent intensity. The addition of OTB resulted in a slight increase in 
fluorescent intensity, while aflatoxin B1 and zearalenone effects were negligible (25). 
Immobilization of aptamers 
A number of approaches have employed immobilization of aptamers, for a wide 
range of matrices, as part of assay formats. Immobilization has the potential for target 
“trapping,” and consequently integrated sample clean-up alongside detection.  
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One such strategy is immobilization of aptamers on 96-well (or other multiwell) 
plates enable a high-throughput format similar to ELISA. Demirkol et al. (2016) created a 
fluorescence assay using 96-well microtiter plates with immobilized aptamers to detect E. 
coli. In this case, 96-well plates coated with poly-l-lysine were specifically used to 
immobilize thiol-modified aptamers by way of sulfo-SMCC (sulfosuccinimidyl-4-(N-
maleimidomethyl) cyclohexane-1-carboxylate) cross-linking chemistry. Sulfo-SMCC 
reacts with the NH2 groups from poly-l-lysine, and forms a maleimide activated carrier, 
and upon addition of the thiol-modified aptamers, in turn, a carrier-aptamer conjugate is 
formed, thereby covalently linking the aptamers to the solid support. Addition of E. coli 
and concurrently quantum dots, enabled fluorescent detection (26).  
Specifically relevant to the current study, Duan et al. (2011) created an aptamer-
based assay for detection of OTA whereby two complementary strands, including one 
(Seq1) immobilized by way of avidin/biotin binding, and one (Seq2) labeled with 
fluorescent (i.e., FAM) reporter, were effectively used to measure OTA (27).  In the 
absence of OTA, a strong background fluorescent signal was measured. In the presence 
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of OTA, Seq1 was bound to the OTA, therefore releasing some of Seq2, and resulting in 
a decrease in fluorescent signal, shown in Figure 3.  
 
Figure 3: Depiction of Duan, et al. (2011) methodology, whereby a high fluorescent signal is present in the 
absence of OTA, and a decrease in signal results upon addition of OTA and release of FAM modified 
strand. 
The LOD of the assay was calculated to be 0.01 ng/mL, or 0.01 ppb (well below 
the EU regulatory guidelines). The authors mention that binding of OTA to aptamers 
relied heavily on Mg2+ and Ca2+ ions and less of K+ (as reflected in the buffers used) (27). 
Objectives 
The use of fluorescently labeled aptamer, paired with complementary quencher, 
as described in previous studies (25), was adapted in the current study to develop a 
multiwell, (i.e., 96-well), plate format assay for OTA. The advantage to using a 96-well 
plate is the ability to perform multiple analyses at the same time with measurements by a 
plate reader. The present research, specifically, utilizes aptamer sequences and 
fluorophore/quencher pairs (i.e., FAM/TAMRA), employed in this and other (27), 
studies. 
In addition, the use of immobilization techniques (for multiwell microtiter plates) 
as described in previous studies (26), (27), were, in turn, explored as a means of 
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developing a functional assay, whereby sample preparation (i.e., “clean-up”) could be 
integrated alongside detection. Approaches included the use of sulfo-SMCC cross-linker 
chemistry to covalently immobilize, and biotin/avidin interactions to non-covalently 
immobilize, aptamers to assay plates. 
Finally, the use of the developed assays, in turn, was assessed with respect to 
OTA in multiple relevant matrices.  These included wine, as a representative (and 
increasingly relevant) agricultural product known and described above.  In addition, 
blood serum – and specifically commercially available fetal bovine serum – was 
investigated towards adapting the technique for biomedical applications. This aspect of 
the study enabled both operational assessment of the assay, and evaluation of the 
potential for a practical application. 
Accordingly, this study had the following specific aims: 
Aim 1: Develop a multiwell plate format aptamer-based assay, specifically using 
fluorescence/quenching, for OTA detection and measurement 
Aim 2:  Develop a multiwell plate format assay that uses an immobilized aptamer, and 
fluorophore/quencher interactions, for “target trapping” prior to detection and 
measurement of OTA 
Aim 3: Evaluation of the developed assay for detection and measurement of OTA in 
relevant matrices including wine and blood serum 
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CHAPTER 2: AN APTAMER-BASED MULTIWELL PLATE ASSAY FOR OTA 
 
Introduction  
Aptamers, previously described in the literature, have been shown to be highly 
specific and increasingly sensitive for target detection. When coupled to a multiwell plate 
format, the assay allows high-throughput analysis of samples with relatively simple 
instrumentation (i.e., plate reader). Figure 4 depicts the proposed assay format from the 
view of a single well. The fluorophore and quencher modified sequences form a duplex 
structure with relatively low fluorescent signal (Figure 4). Upon addition of the target, 
OTA, the fluorophore and quencher modified sequences dissociate, and the fluorophore 
modified sequence forms a “G-quadruplex” structure with OTA, while the quencher 
sequence remains in solution (Figure 4).  
 
Figure 4: Proposed multiwell in solution aptamer-based assay 
The G-quadruplex structure has been described as the proposed folding 
mechanism, due to high amounts of guanine bases in the aptamer sequence. G-
quadruplex structures have been shown to have increased sensitivity and selectivity. 
Basic G-quadruplex structures rely on hydrogen bonding and presence of certain metal 
ions such as as potassium (K+) and sodium (Na+) (28). 
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The fluorophore modified aptamer (e.g., FAM) and the complementary quencher 
(e.g., 10 base pair TAMRA modified) sequence that showed the lowest signal to noise 
ratio in the Chen et al. (2012) study were selected to create a multiwell plate assay for the 
detection and quantitation of OTA. Furthermore, the optimum molar ratio between 
fluorophore modified aptamer and quencher sequences (1:3) were considered for 
adequate quenching of the duplex (25).  
Materials and Methods 
 
Materials 
Fluorophore and quencher modified aptamer sequences were purchased from 
Integrated DNA Technologies (IDT) in Coralville, Iowa with HPLC purification. The 
fluorophore modified sequence was 5’- GAT CGG GTG TGG GTG GCG TAA AGG 
GAG CAT CGG ACA-FAM-3’, and the quencher modified sequence was 5’-TAMRA-
TGT CGG ATG C-3’. 
Corning™ Falcon™ 96-well black/clear tissue culture treated plates were 
purchased from Fisher Scientific. Greiner Bio-One 96-well black/black plates were 
purchased from VWR International. Trizma® hydrochloride (Tris-HCl), potassium 
chloride (KCl), and calcium chloride (CaCl2) were purchased from Sigma-Aldrich (St. 
Louis, MO). Sodium chloride (NaCl) was purchased from Fisher-Scientific (Hampton, 
NH). Water was purified with a Labconco Water Pro PS system at 18.2 megaohms. 
Ochratoxin A, 99+% was purchased from ACROS Organics™. Oligonucleotides and 
OTA stored -20 ͦC. 
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Instrumentation 
Measurements were taken on a Tecan Infinite® M1000 microplate reader with 
excitation 495nm and emission 520nm. The gain was set to automatically adjust 
according to the well with the highest signal (100nM aptamer only), and the z-position 
was automatically set based on scanning volume in wells. 
Assay Procedure 
Stock solutions of the fluorophore modified sequence were made to 10uM and 
quencher modified sequence to 20uM with addition of purified water. The binding buffer 
used for the reaction between duplex and OTA was same as Chen et al. (2012) reported: 
10 mM Tris, pH 8.5, 120 mM NaCl, 5 mM KCl, and 20 mM CaCl2 (25).  Stock solutions 
of OTA were prepared by initially dissolving in methanol, and subsequent dilution in 
binding buffer to give final concentrations (when diluted 50-fold into test wells) 
equivalent to 1, 2, 5, 10, 15, 20 and 30 ng/mL. 
A range of aptamer concentrations (2.5, 5, 10 and 20 pmol per well) were 
evaluated; however, a final concentration of 5 pmol per well of fluorophore modified 
aptamer was found to be sufficient to generate a linear response in the range of 1-20 ppb 
OTA.  Likewise, a 1:2 molar ratio of aptamer to quencher was found to be similarly 
efficient to 1:3 molar ratio employed by the Chen et al. (2012) study, in terms of low 
background fluorescence, and used in the present study. The final working volume of the 
assay was 50 µL with a 1:2 molar ratio (or 100nM:200nM of fluorophore- to quencher-
modified sequences). To prepare the equivalent volume of duplex for each well, 0.5 µL 
of fluorophore strand (10uM) and 0.5 µL of quencher strand (20uM) were added (in a 
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500 µL Eppendorf tube) to 48 µL of binding buffer. The duplex was heated to 88 °C for 5 
minutes and cooled at room temperature for 30 minutes. The duplex (49 µL) was added 
to the 96-well plate, and initial measurements were taken in 1-minute intervals for 10 
minutes (stability of signal).  Next, OTA was added (1 µL) to each well with final 
concentrations ranging from 1, 2, 5, 10, 15, 20, 30 ng/mL (i.e., 1 µL diluted in 49 µL of 
assay buffer). Measurements were taken in 1-minute intervals over 10 minutes with the 
first measurement made within 60 seconds of addition of OTA to the assay.  
Calculations and Statistical Analyses 
All data were normalized, subtracting the buffer control signal, therefore, 
reducing the percent change in fluorescent intensity influenced by the buffer composition. 
The percent change in fluorescent intensity (RFU) was calculated as [(final-
initial)/initial]*100.  The LOD was calculated as 3*(std. error of y-values/slope) and the 
LOQ as 10*(std. error of y-values/slope).  The reproducibility and repeatability were 
measured by the %RSD or the (standard deviation/mean) *100. The accuracy was 
measured by comparing the measured value to the actual value as a percentage of error.  
Subsequent, ANOVA and t-tests were conducted using Excel, data shown in 
corresponding Appendices. 
Results 
A concentration-dependent increase in the percent change in fluorescence was 
observed over the range of 1 to 10 ng/mL OTA, and a linear (R2 = 0.9648) relationship 
was observed from 1 to 20 ng/mL (Figure 4).   The method was further validated in terms 
of sensitivity (i.e., LOD and LOQ) and precision including reproducibility and 
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repeatability (Table 1). Limits of detection and quantitation were calculated as 2.7 ng/mL 
and 8.9 ng/mL, respectively.  The accuracy was measured as a 2.65% error, comparing 
the expected and the true experimental values. The reproducibility (n = 8, 10 ng/mL) was 
calculated as a RSD% of 8.8%, whereas repeatability (n = 10, 10 ng/mL) was measured 
as a RSD% of 5.9% (Table 1). 
 
 
Figure 5: Bar graph showing increasing change in fluorescent intensity with increasing concentration, 
with calibration including dynamic range (0-10ng/mL) 
Table 1: Figures of Merit for solution-based assay 
 
LOD 2.7 ng/mL
LOQ 8.9 ng/mL
Reproducibility 8.8% RSD
Repeatability 5.9% RSD
Accuracy 2.65% Error
Figures of Merit
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 Analysis of Variance (ANOVA) was conducted to determine whether there were 
significant differences between the percent change in fluorescent signals of spiked OTA 
concentrations. The normality of the variables were tested using Kurtosis and Skewness 
values, verifying that Kurtosis values between ± 2 and the Skewness values between ± 1. 
The subsequent ANOVA output for the comparison of group means of 0, 1, 2, 5, 10, 15, 
20 ng/mL with 5 replicates is shown in Appendix 2: Table 5. The null hypothesis is that 
all group means are equal. The F value is greater than the critical value of F meaning that 
the null hypothesis is rejected (15.49 > 2.45). Furthermore, the p-value is 9.39 x 10-08 < 
0.05 indicating a significant difference between group means, or percentage change in 
fluorescent signal. Additional t- tests were performed to determine which groups were 
different from each other. Appendix 2: Table 6 shows the t-test results for the comparison 
of the percent change in fluorescent intensity signal for 0 and 1 ng/mL and the percent 
change in fluorescent intensity signal for 1 and 5 ng/mL. The p-value for the t-tests 
comparing 0 and 1 ng/mL and 1 and 5 ng/mL were 0.0366 < 0.05 and 4.88 x 10-08 < 0.05, 
respectively, depicting a significant difference in the percent change of fluorescent signal. 
Furthermore, Appendix 2: Table 7 shows the t-tests for the comparison of 1 and 15ng/mL 
(left) and the comparison of 1 and 20ng/mL (right) with p-values 0.0683 > 0.05 and 7 x 
10-07 < 0.05, respectively. The p-values chosen are the ones for the two-tailed test which 
determines if there is any significant difference between the signals, including both 
greater than or less than. The difference between 1 and 15ng/mL was shown as not 
significant; however, the value was significant for the one-tailed test (0.0341 > 0.05).  
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Discussion 
The aptamer-based method developed in the present study demonstrated a 
concentration-dependent fluorescent response for detection and quantitation of OTA with 
sensitivity which is potentially sufficient for agricultural and biomedical applications. 
The LOD and LOQ for the solution-based assay of spiked OTA samples were 2.7 ng/mL 
and 8.9 ng/mL, respectively. The EU’s regulatory guidelines prohibits levels in wine, for 
example, is currently 2 ng/mL, and the developed method would enable detection at this 
limit.  On the other hand, current guidelines for OTA in various commodities for the 
United States, Canada, and the European Union are depicted in Table 2. The United 
States does not currently have regulations or maximum limits on OTA in foodstuffs. 
However, both Canada and the European Union have implemented limits using current 
and past research. Both Canada and the European Union have limits at 3 ng/mL for grains 
of direct consumption and cereal products. 
Table 2: Maximum concentrations for commodities as provided by the United States (no guidelines), 
Canada (29), and the European Union (30).  
 
Max concentration (ng/mL)
Commodity United States Canada
a
European Union 
b
Grains- direct consumption - 3 3
Derived cereal products - 3 3
Cereal food for infants - 0.5 0.5
Dried vine fruit - 10 10
Roasted coffee - - 5
Grape juice and related products - 2 2
Wine - - 2
a 
Canada Proposed Maximum Limits 2009 
b
 European Commission Maximum Levels 2006
 
19 
 
Additionally, a study testing OTA in serum was conducted by Malir et al. (2013) 
with 100 pregnant women in their first trimester, ages 19-40 years, in the Czech 
Republic. The blood serum levels were tested by HPLC-FD and compared with dietary 
consumption. The range of incidence of OTA in blood serum was between 0.1-0.35 
ng/mL, with an average of 0.15 ng/mL. However, these values are similar to those who 
were not pregnant and eating comparable foodstuffs, indicating the relationship between 
contaminated foods and serum levels (31). Furthermore, urine has been used as a matrix 
to measure OTA levels in humans. Pascale et al. (2001) measured spiked human urine 
levels between 0.05-1ng/mL by HPLC-FD (32). 
The LOD/LOQ for the current assay were, however, lower than previously 
reported by Chen et al. (2012) for a similar approach (i.e., 0.08 ng/mL). Potential 
explanations for the higher values (and lower sensitivity) may be related to the difference 
between the optical capabilities of the two formats (i.e., use of a cuvette versus a 96-well 
plate format). More specifically, it may be affected by the plates used. There are, in fact, 
a variety of microtiter plates for 96-well plate assays. However, black plates with black 
(i.e., opaque) or clear bottoms are most often used for fluorescent assays. Both 
black/black and black/clear plates were tested in the current study to observe differences 
in percentage change of fluorescent intensity by way of bottom or top read. The solution-
based assays used black plates with clear bottoms and the immobilized assays used black 
with black plates. Precision of the assay was estimated by taking measurements to 
calculate reproducibility and repeatability. The reproducibility (%RSD) of the assay was 
determined to be 8.8% whereas repeatability was 5.9%, and may be, likewise, dependent 
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upon the optics and precision of the instrumentation, i.e., plate reader (discussed further 
in Chapter 3). 
The concentration of fluorophore modified aptamer was also tested at a range of 
concentrations including 2.5, 5, 10, and 20 pmol per well. The 5 pmol/well concentration 
was chosen in the study because it had the most stable and linear increase in relationship 
among various spiked OTA concentrations, whereas 2.5 pmol/well concentration of 
fluorophore-modified aptamer did not show a significant difference between aptamer and 
duplex signals. Additionally, 10 pmol and 20 pmol concentrations were tested, however, 
5 pmol was found to be similarly efficient in terms of detection of spiked OTA in 
relevant ranges of concentrations (Figure 7). The result agrees with the previous studies, 
Chen et al. (2012), which employed an equivalent concentration of fluorescently labeled 
aptamer. The Duan et al. (2011) study uses 50nM concentration of aptamer, however, 
fails to mention the working volume of the assay. Finally, the larger distinction between 
0-5 ng/mL in the 5pmol concentration provides the opportunity for greater sensitivity 
between those concentrations. 
Taken together, these results suggest that the proposed assay may, in principle, 
provide a format suitable for high-throughput detection of OTA. To further assess this 
potential, relevant matrices must be assessed. However, anticipating a potential 
contribution of interfering species within these complex biological matrices, I first 
investigated the possible use of aptamer immobilization within the current assay format 
as a means of integrated sample preparation via “target trapping” (Chapter 3). 
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Figure 6: Comparison of fluorophore-modified aptamer pmol concentrations 
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CHAPTER 3: A MULTIWELL PLATE ASSAY FOR OTA BASED ON 
IMMOBILIZED APTAMER  
 
Introduction 
 Modification of the aptamer fluorescence quenching assay (as discussed in 
Chapter 2) based on the immobilization of the OTA-specific aptamer was investigated. It 
was proposed that immobilization of aptamers would enable a simplified and integrated 
sample preparation and clean-up by removal of potential interferences by way of target-
trapping and subsequent washing steps. The proposed approach is depicted in Figure 7, 
where the duplex is immobilized to 96-well test plates by way of cross-linker (i.e., biotin-
avidin or thiol chemistry), and upon addition of OTA, the quencher strand is released, 
and can be removed (by washing), to enable specific measurement of fluorescent signal 
generated by presence of OTA. 
 
Figure 7: Depiction of immobilization of fluorophore/quencher sequence 
 
 Three sets of aptamer configurations and immobilization techniques were 
explored in which the fluorophore modified sequence was immobilized by either thiol-
based (i.e., SMCC) chemistry at the 5’ end, or by biotin modifications at either the 5’ or 
3’ ends (see Appendix 1).  
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Materials and Methods 
 
Materials 
Aptamer sequences modified with fluorophore (FAM) and quencher (TAMRA), 
and modifications (i.e., thiol and biotin) were purchased from Integrated DNA 
Technologies (IDT) in Coralville, Iowa with HPLC purification. The fluorophore-labeled 
sequences were as follows: 5’-/Biotin-TEG/GAT CGG GTG TGG GTG GCG TAA 
AGG GAG CAT CGG ACA-FAM-3’ (5BIOTIN), 5’-/56-FAM/ TGA TCG GGT GTG 
GGT GGC GTA AAG GGA GCA TCG GAC A /3BioTEG/-3’ (3BIOTIN), and 5’-
/ThioMC6-D/ GAT CGG GTG TGG GTG GCG TAA AGG GAG CAT CGG ACA/36-
FAM/-3’. The quencher sequences were as follows: 5’-TAMRA-TGT CCG ATG C-3’ 
(5TAMRA) and 5’ CCC ACA CCC GAT T /36-TAMSp/-3’ (3TAMRA). 
Pierce™ Streptavidin Coated High Capacity Plates, 96-well plates, black/black 
were purchased from ThermoFisher Scientific and stored at -20 ̊C. Corning Poly-D-lysine 
coated 96- well polystyrene plates, black/clear were purchased from Sigma Aldrich (St. 
Louis, MO). Chemicals including magnesium chloride (MgCl2), tris(2-carboxyethyl) 
phosphine (TCEP), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
Trizma® hydrochloride (Tris-HCl), potassium chloride (KCl), and calcium chloride 
(CaCl2) were purchased from Sigma-Aldrich (St. Louis, MO).  Sodium Chloride (NaCl) 
and Sulfo-SMCC No-Weigh Format (8 X 2mg microtubes) were purchased from Fisher-
Scientific (Hampton, NH). Water was purified with a Labconco Water Pro PS system 
(18.2 megaohms). Ochratoxin A, 99+% was purchased from ACROS Organics™. 
Oligonucleotides and OTA stored -20 ͦC. 
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Instrumentation 
 Measurements were taken on a Tecan Infinite® M1000 microplate reader with 
excitation 495 nm and emission 520 nm. The gain was set to automatically adjust using 
the well with the highest signal (100 nM aptamer only), and the z-position was 
automatically set based on scanning volume in wells. Additionally, comparative 
measurements were taken on a Biotek Synergy HT or Biotek Synergy 2 plate-reader, 
specifically using filters for 485/20 nm excitation and 528/20 nm emission. Likewise, the 
gain was set on these instruments to the well with the highest signal (100 nM aptamer 
only), and subsequently used throughout the procedure. 
Immobilization of Aptamers 
 Aptamers were immobilized on 96-well plates using either biotin/streptavidin 
interactions, or covalent linkage via sulfo-SMCC reaction with poly-D-lysine coating on 
plates. Both approaches were subsequently evaluated in assays of OTA. 
 For biotin-modified aptamers, an excess of quencher (1:2 molar ratio for 
fluorophore to quencher aptamer) was used; accordingly 0.5 µL of 10 µM 5BIOTIN or 
3BIOTIN aptamer, and 0.5 µL of 20 µM of 5TAMRA or 3TAMRA quencher strand were 
combined in a 500 µL Eppendorf tube, with 49 µL binding buffer.  Stock solutions (10 
µM biotinylated aptamer, 20 µM TAMRA-modified quencher) were prepared in 
sterilized water, and stored at -20 ̊C. The binding buffer used for 5BIOTIN/5TAMRA 
was 10 mM Tris, pH 8.5, 120 mM NaCl, 5 mM KCl, and 20 mM CaCl2, the same as the 
solution-based assay.  The binding buffer for 3BIOTIN/3TAMRA was 10 mM HEPES, 
120 mM NaCl, 5 mM KCl, 20 mM MgCl2, 20 mM CaCl2, pH 7.0. Aptamer/quencher 
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mixtures were heated to 88 ̊C for 5 minutes, and allowed to cool for 30 minutes at room 
temperature, to form duplexes. The duplex (50 µL) was subsequently added streptavidin-
coated plate, and incubated for 60 min at room temperature. 
 Secondarily, an immobilization procedure using poly-lysine and sulfo-SMCC was 
investigated (26). TCEP (1mM, IDT recommendation 100x excess) was used to break the 
disulfide bonds on the thiolated aptamer, and prepare aptamer for subsequent 
immobilization. A solution of sulfo-SMCC (2 mg/mL) in water was prepared, and 50 µL 
of this solution was added to each well of a poly-D-lysine coated, 96-well plate, which 
was placed on a rotary shaker for 2 hours at room temperature. Wells were rinsed with 
water, and allowed to dry.  Following similar procedures as used for biotin-modified 
aptamers, a 1:2 molar ratio of fluorophore modified sequence (0.5 µL of 10 uM solution), 
to quencher modified sequence, (0.5 µL of 20uM solution) were added to a 500 µL 
Eppendorf Tube with 10 mM Tris, pH 8.5, 120 mM NaCl, 5 mM KCl, and 20 mM CaCl2 
binding buffer (49 µL). The aptamers were incubated on plates overnight at room 
temperature before being used for assays. 
Assay Procedure 
Aptamer assays were generally conducted similar to the technique described in 
Chapter 2. Measurements (n=10) of immobilized duplexes were taken at 1-minute 
intervals for 10 minutes to acquire the initial fluorescent readings. The wells, containing 
immobilized aptamers, were then washed with 0.01M PBS, and refilled with binding 
buffer. Measurements (n=10) at 1-minute intervals were then taken to determine the 
change in signal due to possible loss of non-immobilized following washing step. Finally, 
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1 µL aliquots of OTA, prepared at a range of concentrations (0-20 ppb) were added to the 
test wells, and a final set of 10 measurements (at 1-minute intervals) were made. 
Calculations and Statistical Analyses 
All data were normalized by subtracting the buffer control signal, therefore, 
reducing the percent change in fluorescent intensity influenced by the buffer composition. 
The percent change in fluorescent intensity (RFU) was calculated as [(final-
initial)/initial]*100. Subsequently, ANOVA and t-tests were conducted using Excel 
(output of these analyses are shown in corresponding Appendices). 
Results 
To show that the quenching mechanisms work for the immobilization procedures 
of 5BIOTIN and 3BIOTIN, the relative fluorescent units were compared for the aptamer 
signal, the buffer signal, and the duplex signal (aptamer and quencher combined).  Figure 
8 shows the fluorescence of aptamer with and without quencher from 10 measurements. 
When the aptamer and quencher sequences are added together, a significant reduction in 
fluorescence was observed, and approached the signal intensity of buffer-only controls.  
   
Figure 8: Quenching mechanism significantly reduces RFU for 5BIOTIN assay (left) and 3BIOTIN assay 
(right). 
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 Figure 9 shows the calculated percent change in fluorescent intensity upon 
addition of spiked OTA, in methanol, to 5BIOTIN/5TAMRA duplex. A single factor 
ANOVA was used to assess the significant differences in the percent change of 
fluorescent intensity across various concentrations (0, 1, 5, 10, 20 ng/mL). The ANOVA 
provided a p-value of 0.3211 > 0.05, showing that there was no significant difference 
among percent change in fluorescent intensity for various concentrations (Appendix 3: 
Table 8).  
 
Figure 9: Change in relative fluorescent intensity upon addition of OTA to immobilized aptamers 
To further investigate, the 5BIOTIN assay was evaluated on a similar (Biotek 2) 
instrument. Figure 10 shows that the change in fluorescent intensity was found to 
increase, but all measurements curiously represented negative changes in fluorescence. 
Potential reasons for this negative change in fluorescence could include the 
conformational change of the aptamers upon addition of the OTA was unsuccessful or 
there were instrumental issues. 
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Figure 10: 5BIOTIN assay with increasing change of fluorescent intensity. 
 Immobilization and assay procedures were next conducted for 
3BIOTIN/3TAMRA in duplicate. Figure 11 shows the relative change in fluorescent 
intensity for 0, 1, 5, 10 and 20 ng/mL OTA. An apparent effect on concentration on 
fluorescence response was observed over this range. An ANOVA single factor was 
conducted to test if there were any significant differences between concentrations, 
however, the p-value 0.196 > 0.05 indicated no significant difference among the 
percentage change in fluorescent intensity (Appendix 3: Table 9).  
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Figure 11: Change in fluorescent intensity of 3BIOTIN 
Two buffers, namely TRIS and HEPES, were evaluated in the 5BIOTIN assay 
(Figure 12). Results confirmed a lack of concentration-dependent increase in 
fluorescence, as expected for the proposed assay, and moreover, showed no significant 
difference between the two buffers. A two-factor ANOVA was performed to analyze the 
statistical significance of Tris vs. HEPES buffer on each of the assays respectively 
(Appendix 3: Table 10). The p-value for concentration was 0.6506 > 0.05, concluding 
that there was no significant difference in the percent change of fluorescent intensity in 
concentrations for the two buffers. Furthermore, the p-value for the percent change in 
fluorescent intensity comparing buffers among concentrations was 0.4123 > 0.05, 
concluding the buffers were not statistically different. Lastly, the p-value for the 
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interaction between concentration and buffer was 0.1112 > 0.05, indicating there is no 
significant interaction between concentration and buffer type (Tris vs. HEPES).  
 
Figure 12: Comparison of HEPES and Tris buffers used in 5Biotin assay 
Finally, immobilization of thiol-modified aptamer via SMCC-linking chemistry 
was investigated. However, the duplex did not appear to effectively immobilize to the 
bottom of the well, and washed off during the 1st and 2nd washing steps (PBS1, PBS2) as 
shown in Figure 13. The readings after each washing step show a significant decrease in 
signal from binding buffer (BB) to PBS1 and PBS 2, where almost a complete loss of 
relative fluorescent signal was observed.  
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Figure 13: Average relative fluorescent units (RFU) indicating loss of fluorescent signal over two washing 
steps 
 
Discussion 
 Fluorescence response of the immobilized 5BIOTIN/5TAMRA duplex did not 
indicate a linear relationship with OTA concentration upon initial assessments (Figure 9). 
The average percent change in fluorescent intensity for 0, 5, and 10 ng/mL spiked 
samples resulted in values of 12.92, 13.11, and 13.88%. This indicates a lack of 
concentration-dependent relationship with OTA. Additionally, the standard deviation for 
the percent change in fluorescent intensity of 20 ng/mL provides a range of signal from 
12-50%, indicating the lack of sensitive detection, overlapping with the concentrations 0, 
5, and 10 ng/mL (Figure 9). When testing the 5BIOTIN assay on a separate plate reader 
(Figure 10), all signals were negative with decreasing negativity as concentrations 
increased. Reasons for this could be instrumentational issues or that the quencher is 
working incredibly well, so the conformational change upon addition of OTA and 
subsequent fluorescent signal, was being quenched.  
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 Upon further review of the Duan et al. (2011) study, I decided to incorporate the 
approach of heating the 96-well plate prior to assays. Heating aptamers enables 
unraveling and opening of conformational structure to assist in the binding of OTA and 
displacement of the quencher strand. Due to instrumentation downtime, this method was 
not attempted on the Tecan M100 Infinite, but instead evaluated on a Biotek Synergy HT 
plate reader. Upon heating this assay for 40 minutes at 45 ͦC and using the relevant 
percentage change in fluorescent intensity calculation, no significant change in 
fluorescent signal with increasing OTA concentration was detected. The percentage 
change in fluorescent signal for the duplex with 0 ng/mL OTA increased, more so than 
those duplexes spiked with 1, 5, 10, and 20 ng/mL OTA. The reason for this is unknown, 
but it is possible that the heating step dissociated some portion of the quencher from this 
duplex, therefore, increasing the fluorescent signal upon measurement. 
 Based on the lack of success of the 5BIOTIN assay, an alternative aptamer 
configuration was evaluated, specifically the addition of the biotin modification to the 3’ 
was investigated (3BIOTIN). However, similar results were achieved in which a lack of 
concentration-dependency was noted. 
 Optically, the immobilization of aptamers to the bottom of a multiwell plate may 
restrict the emitted fluorescent signal, in terms of the solution dynamics within the test 
well. The excitation wavelength in this case needs to travel through the solution to the 
bottom of the well, potentially posing interference or scattering effect before reaching the 
aptamer duplexes. The distribution of duplexes on the bottom of the well is not known, or 
characterized here, and may limit emission and, thus, measured signal.  
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Changing the aptamer configuration to a biotin modification on the 3’ end, and 
the fluorophore modification to the 5’ end, required a new quencher sequence that would 
be complementary. As the quencher for the solution-based assay and the 5BIOTIN assay 
appeared to be functional, a similar complementary 13-base pair sequence was selected 
for the 3BIOTIN assay. Although a 10-base pair sequence would have been more similar 
to the 5BIOTIN assay, for purposes of adding the quencher (TAMRA) to the 3’ end 
certain base pair additions were required (i.e. TAMRA requires T following). Results 
indicated a lack of concentration-dependent fluorescent change, potentially resulting from 
the quencher sequence. The quencher sequence was chosen based on functionality of the 
5BIOTIN assay, however, shorter or longer sequences may be more suitable.  
 Finally, use of SMCC-linking chemistry was investigated. The thiol modified 
assay lost over 98% in signal from washing which suggests that the immobilization 
procedures were not successful. Immobilization issues could have resulted from the 
operational variables including reconstitution of aptamer in purified water, and then 
subsequent dilution with concentrated TCEP (to break disulfide bonds), instead of initial 
reconstitution in TCEP.  
 Taken together, immobilization techniques investigated here were not shown to 
be effective either in terms of sufficiently stable immobilization, or utility for detection of 
OTA-induced fluorescence changes of the fluorophore/quencher aptamer pairs. 
Subsequent studies, therefore, focused on solution-based approaches to the aptamer 
assays. 
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CHAPTER 4: APPLICATION OF APTAMER-BASED ASSAY FOR OTA TO 
RELEVANT MATRICES 
 
Introduction 
The overarching aim of the study was development of aptamer-based methods to 
quantitate OTA for application to relevant biological matrices. Included among the 
matrices investigated were wine, as a relevant agricultural product, and blood serum in 
relation to biomedical applications (i.e., detection of OTA exposure). The growing 
market for wine consumption, as discussed in Chapter 1, has brought around an emerging 
need for mycotoxin detection in wine samples.  As a result of OTA in various agricultural 
products, this and other mycotoxins have been found in human blood serum indicating 
exposure, and furthermore, enabling investigation of the contribution of this exposure - 
and assessment of exposure levels - relative to possible health effects (e.g., 
carcinogenicity).   
Contamination of foodstuffs is highly dependent on the type of crop, and the 
stages of processing. The two most common fungi species responsible for OTA 
production are Aspergillus and Penicillium (11). During the wine-making process, the 
key factors that influence OTA contamination is water availability, temperature, and pH  
(6) (33). OTA has been detected in a variety of wines around the world, although most 
recently, a study of U.S. wines showed both widespread occurrence, and high levels, of 
OTA (17).  
With respect to human exposure, and possible health effects, OTA has been 
reported in blood serum, and linked to occurrence of negative health outcomes (e.g., 
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nephropathy, cancer). Khlifa et al. (2008), for example, conducted a study where 105 
serum samples were taken from healthy patients, and 131 serum samples were taken from 
nephropathic patients (reported to be related to OTA consumption), in Tunisia. Of the 
105 healthy subjects, 28% tested positive for OTA with a mean of 0.49 ± 0.67 ng/mL. Of 
the 131 nephropathic patients, 61% tested positive for OTA with a mean of 0.98 ± 1.15 
ng/mL. The study concluded that chronic interstitial nephropathy appeared to be 
associated with higher levels of OTA in the serum (34). 
A variety of high-throughput approaches have been explored for effective 
extraction of OTA from complex matrices such as wine and fetal bovine serum. Both of 
these matrices present challenges. It has been previously shown, for example, that 
phenolics present in wines may interfere with analyses, and specifically aptamer (and 
immunoaffinity, e.g., ELISA) based techniques (15) as developed in the present study. 
On the other hand, it has been shown that OTA binds readily to serum albumin proteins, 
and represents a challenge to extraction techniques for this matrix. Alongside assessment 
of the aptamer-based assay (developed in the current study) for quantitative analysis of 
OTA in wine and blood serum, extraction methods for each matrix were evaluated by 
conventional methods (i.e., HPLC-FD; De Jesus et al., 2018). Taken together, the goal 
was to develop and assess the aptamer-based assay technique for application to these 
relevant biological matrices.   
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Materials and Methods 
Materials 
Fluorophore and quencher sequences were purchased from Integrated DNA 
Technologies (IDT) in Coralville, Iowa with HPLC purification. The fluorophore 
sequences are as follows: 5’-/Biotin-TEG/GAT CGG GTG TGG GTG GCG TAA AGG 
GAG CAT CGG ACA-FAM-3’ (5BIOTIN), 5’-/56-FAM/ TGA TCG GGT GTG GGT 
GGC GTA AAG GGA GCA TCG GAC A /3BioTEG/-3’ (3BIOTIN). The quencher 
sequences are as follows: 5’-TAMRA-TGT CCG ATG C-3’ (5TAMRA) and 5’ CCC 
ACA CCC GAT T /36-TAMSp/-3’ (3TAMRA). 
Pierce™ Streptavidin Coated High Capacity 96-well plates (black/black) were 
purchased from Thermo-Fisher Scientific, and stored at -20 ̊C.  Chemicals including 
magnesium chloride (MgCl2), tris(2-carboxyethyl) phosphine (TCEP), 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), Trizma® hydrochloride (Tris-
HCl), potassium chloride (KCl), and calcium chloride (CaCl2) were purchased from 
Sigma-Aldrich (St. Louis, MO).  Water was purified with a Labconco Water Pro PS 
system (18.2 megaohms). Ochratoxin A, 99+% was purchased from ACROS Organics™. 
Oligonucleotides and OTA stored -20 ͦC. Eppendorf tubes (1.5 mL capacity) were 
purchased from Aquarious. Centrifuge tubes (15 mL capacity) and autosampler vials (1.8 
mL capacity) were purchased from VWR International. Autosampler 12 x 32 mm screw 
top caps, and 200 µL glass inserts were purchased from Microsolv Technology 
Corporation. Solvents including acetonitrile, acetic acid, water (HPLC grade), 
chloroform, ethyl acetate, and hydrochloric acid were purchased from Fisher Chemical. 
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Internal standard for HPLC, 7-methoxycoumarin, was purchased from SigmaAldrich (St. 
Louis, MO). 
Red wine (Yellowtail® Merlot 2015) was purchased from a local (Publix) 
supermarket. As a proxy for blood serum, fetal bovine serum (from USDA approved 
countries) was purchased from Sigma-Aldrich, and stored, until use, at -20 ̊C. 
Assay Instrumentation 
Measurements were taken on a Tecan Infinite® M1000 microplate reader with 
excitation 495 nm and emission 520 nm. The gain was set to automatically adjust using 
the well with the highest signal (100 nM aptamer only), and the z-position was 
automatically set based on scanning volume in wells. Additionally, some measurements 
were taken on a Biotek Synergy 2 plate reader, whereby the filter was set to 485/20 nm 
excitation and 528/20 nm emission. The gain was, likewise, measured as the well with 
the highest signal (100nM aptamer only), and subsequently used throughout the 
procedure. 
Aptamer Assay Procedure 
Aptamer assays were generally performed as previously described (in Chapter 2) 
with modifications, as discussed below. Briefly, an equivalent volume of duplex was 
prepared for each well, and consisting of 0.5 µL of fluorophore strand (10uM) and 0.5 µL 
of quencher strand (20uM) added) to 48 µL of binding buffer (in a 500 µL Eppendorf 
tube). The duplex was heated to 88 °C for 5 minutes, and cooled at room temperature for 
30 minutes. The duplex (49 µL) was added to the 96-well plate, and initial measurements 
were taken in 1-minute intervals for 10 minutes (stability of signal). Measurements were 
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taken in 1-minute intervals over 10 minutes (n = 10). Next, OTA-containing sample (i.e., 
spiked wine or serum, or extracts) was added in 1 µL to each well to give appropriate 
concentration ranges (i.e., 1 µL diluted in 49 µL of assay buffer). Measurements were 
taken in 1-minute intervals over 10 minutes, with the first measurement made within 60 
seconds of addition of OTA to the assay.  
Wine 
A variety of methods were investigated for extraction of OTA, and introduction 
into assays. Initially, spiked wine was added directly to the assay, however, to mitigate 
potential interferences other methods were explored. One method included simple 
dilution: 450 µL of red wine was diluted to 45 mL in Tris binding buffer, creating a 1% 
wine solution, to dilute possibly interfering species (e.g., phenolics). Secondly, wine was 
extracted using a previously developed, De Jesus et al. (2018), liquid/liquid extraction 
(LLE) method specifically using chloroform, and reconstitution of extracted OTA in 
either binding buffer or organic solvent (i.e., methanol).  
Recognizing that phenolics present in wines may interfere with aptamer-based 
detection, a method to remove phenolics from wine was investigated. Specifically, the 
addition of polyvinylpyrollidone (PVP) to wine samples as previously reported (15). 
Briefly, 400 µL of a 20 ug/mL solution of PVP-40 in water was added to a 2 mL aliquot 
of wine, shaken at room temperature for 5 minutes, centrifuged for 10 minutes at 6000 
rpm, pH was adjusted to 7.5 by addition of 1M sodium hydroxide (NaOH), and filtered 
with 0.22 micron filter (15).   
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Fetal Bovine Serum 
Fetal bovine serum (FBS) was employed to investigate the ability to extract, 
recover and measure OTA using the aptamer assay. Aliquots of FBS were portioned and 
stored in 15-mL polypropylene centrifuge tubes for subsequent studies. Sub-aliquots of 
FBS were spiked with relevant concentrations of 0, 50, 250, 500 and 1000 ng/mL OTA 
(0, 1, 5, 10, 20 final concentration in assay with 1:50 dilution) in methanol.  
Two extraction methods for serum were investigated for application to the 
aptamer assays. The first method utilized a simple LLE with chloroform whereby a 500 
µL aliquot of OTA-spiked serum was extracted with 1mL of chloroform, and subsequent 
operating procedures similar to that used for LLE of wine (i.e. vortex, remove 
supernatant, dry, reconstitute). After verifying by HPLC-FD that this method was 
insufficient to extract OTA from serum a multi-step extraction, previously reported (35), 
was explored. In this method, 1mL of serum spiked with OTA concentration was 
combined with 5 mL of a 1:1 mixture of 0.2 M magnesium chloride (MgCl2) and 0.1 M 
hydrochloric acid (HCl), and mixed for 1 minute (35). After mixing, 3 mL of chloroform 
was added to the mixture, shaken, and centrifuged at 768xg RCF for 5 minutes. The 
bottom chloroform layer was removed and dried down under a stream of air. The water 
layer was removed and the extraction was conducted again by adding 3 mL of 
chloroform. The chloroform layer was removed and added to the other, dried down under 
a stream of air, and reconstituted with 1 mL of methanol. 
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HPLC-FD of OTA 
To evaluate the effectiveness of extraction techniques for wine and serum, a 
previously described HPLC-FD method, De Jesus et al. (2018), was employed to quantify 
OTA. For analyses, samples were reconstituted in either binding buffer or methanol, and 
effectiveness of both were subsequently compared by HPLC-FD. Calibration curves, 
covering a relevant range of OTA concentrations, were generated. Specifically, OTA was 
reconstituted and diluted in 200 µL of HPLC mobile phase (i.e., water, acetonitrile and 
2% glacial acetic acid, 49.5:49.5:1), and transferred to HPLC amber vials containing 200 
µL inserts.  
For HPLC-FD measurement of OTA, a Shimadzu Prominence UFLC system with 
an autosampler and fluorescence detector, and equipped with a Sonoma C18(2) column 
(5µm, 100 Å pore size, 250mm x 4.6mm, ES Industries, West Berlin, NJ, USA), was 
used. The injection volume was 20 µL, and separation was achieved by an isocratic 
elution (water, acetonitrile and 2% glacial acetic acid, 49.5:49.5:1) at 1.0 mL/min. 
Fluorescent detection was conducted using 333nm excitation and 460nm emission.  
HPLC-UV/Vis/FD of Phenolics 
 To assess phenolics in wine and potential application of PVP for removal of 
phenolics(see above), in HPLC-UV/Vis/FD technique was modified from Rodriguez-
Delgado et al. (2001) and employed. Briefly, 1 mL of wine was transferred to a 15 mL 
polypropylene centrifuge tube to which 1 mL of diethyl ether was added, followed by 
vortexing (10 s), and equilibration (10 min). The organic supernatant layer was removed, 
and dried under a stream of air. The phenolic extract was reconstituted in methanol: water 
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(1:1), and analyzed by HPLC-UV/VIS/FD using a Waters Nova-Pak® C16 column 
(4µm, 3.9 x 300mm, Ireland). Analytical separation was achieved using a gradient elution 
of solvent A (methanol:acetic acid:water, 10:2:88) and solvent B (methanol:acetic 
acid:water, 90:2:8) as follows: 0 to 15 min, 100% to 85% solvent A; 15 to 25 min, 85% 
to 50% solvent A; 25 to 34 min, 50% to 30% solvent A. Phenolics were measured using a 
photodiode array detector (200-450nm), and fluorescence detection (excitation 278nm, 
emission 360nm), as described (36). 
Calculations and Statistical Analysis 
All data were normalized, subtracting the buffer control signal, therefore, 
reducing the percent change in fluorescent intensity influenced by the buffer composition. 
The percent change in fluorescent intensity (RFU) was calculated as [(final-
initial)/initial]*100. The LOD was calculated as 3*(std. error of y-values/slope) and the 
LOQ as 10*(std. error of y-values/slope).  The reproducibility and repeatability were 
measured by the %RSD or the (standard deviation/mean) *100. Recoveries were 
calculated based on the linear regression of ΔRFU versus OTA concentration from 
calibration curves (RFU= m [OTA] + b, where m and b are slope and y-intercept of the 
regression), and percent recovery was calculated based on the measured versus the 
actual concentration of OTA. Statistical tests, including ANOVA and t-tests, were 
conducted using Excel (output is given in Appendices). 
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Results 
 
OTA in Wine 
Ability of the aptamer-based assay to measure OTA in wine was assessed in 
toxin-spiked wine samples.  The wine used in these studies was confirmed by HPLC-FD 
not to have OTA aside from that spiked into aliquots.  The wine was subsequently spiked 
with OTA at a concentration range of 0, 50, 250, 500, 1000, and 1500 ng/mL (giving 
final concentrations, after 1:50 dilution, of 0, 1, 5, 10, 20, and 30ppb). Initially, aliquots 
(1 µL) of spiked wine samples were diluted into test wells. No clear concentration 
dependent increase in fluorescence was observed, although, both 20 and 30 ng/mL have 
positive changes (Figure 14). 
 
Figure 14: Wine samples (neat) spiked with OTA added to wells in 1 µL volumes 
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As an alternative approach, wine was subsequently diluted to 1% with binding 
buffer, and then spiked with varying OTA levels, which were subsequently diluted once 
more, upon addition to 96-well plate. Back calculating, 5 ng/mL would, therefore, 
correspond to a 500 ng/mL concentration of OTA in the wine. Upon addition of 10 µL of 
1% wine with no OTA, there was still detectable background signal. However, there 
appears to be a concentration-dependent increase in the measured fluorescent response 
(Figure 15).  
 
Figure 15: Wine diluted 100 fold with binding buffer and spiked with OTA 
Next, wine samples were spiked and extracted following previously developed 
(De Jesus et al., 2018) method of LLE. Initialy, extract was reconstituted and 
concentrated with 100 µL of binding buffer. However, no concentration-dependent 
increase in fluorescence was discernible, and very high error (i.e., standard deviation) in 
the response was observed (Figure 16). 
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Figure 16: Extracted OTA using liquid/liquid extraction added in 10 µL volumes 
  To investigate the potential interference of phenolics present in wine and extracts, 
PVP was added to wine to remove potentially interfering phenolics as previously 
described as a “fining” method for wine (15), (37). Addition of PVP to wine showed no 
improvement of the concentration-dependency of the fluorescence response for either 
directly diluted wine or wine extracts (Figure 17). 
     
Figure 17: In solution assay using PVP/wine/chloroform extract method 
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To further assess the ability of PVP to reduce phenolics, HPLC-UV/Vis/FD was 
utilized to analyze PVP treated and untreated wine. As shown in Figure 18, the addition 
of PVP to wine had no discernible effects on the levels or composition of the major 
phenolic components.  
 
Figure 18: Individual chromatograms for phenolic separation with PVP extracted wine 
 
 Finally, to evaluate the effect of the solvent used to reconstitute OTA in wine 
extracts, the use of binding buffer (as initially employed) was compared, by HPLC-FD, to 
methanol as a recovery solvent. As shown in Figure 19, methanol was clearly a more 
effective solvent for recovery of OTA following extraction (corresponding 
chromatograms are given in Appendix 4 (Figure 25 and 26). Recoveries for methanol 
were approximately 78-90%, whereas when reconstituted in binding buffer, only 0-4% of 
OTA was recovered (Table 3). 
7-MC 
7-MC 
 
46 
 
 
Figure 19: Comparison of wine reconstitution with OTA calibration curve 
Table 3: Recoveries of wine in methanol and binding buffer 
 
 Based on the obvious improvement of OTA recovery using methanol, the aptamer 
assay was repeated with extracts of wine reconstituted in methanol. A clear 
concentration-dependent response was observed, and a highly linear relationship (R2= 
0.97) between fluorescent change and OTA concentration was found in the relevant range 
of 0-20ppb (Figure 20). The calculated LOD and LOQ were found to be 4.4 ng/mL and 
14.7 ng/mL, respectively, and higher than observed for OTA alone (See Chapter 2).  
Recoveries % 50 250 500 1000
Wine Meth 78.7374 82.1552 89.6555 87.3264
Wine BB 0 2.68792 2.6199 3.76197
Concentration (ng/mL)
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Figure 20: Bar graph showing increasing change in fluorescent intensity with increasing concentration, 
with calibration including dynamic range (0-20ng/mL) 
 
OTA in Serum 
As a proxy for blood serum, commercially available FBS was spiked with various 
concentrations of OTA (from 0, 50, 250, 500, 1000 ng/mL, and corresponding to final 
concentrations of 0, 1, 5, 10, 20 ng/mL in the assays). As for serum, spiked FBS (1µL) 
was initially diluted directly into assay wells. As shown in Figure 21, no concentration-
dependent increase in fluorescent change was observed.  
* 
* 
* 
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Figure 21: Change in fluorescent intensity upon addition of spiked BFS in solution-based assays for 2 
replicates  
 
Extraction of OTA-spiked serum was investigated. Initially, a simplified LLE 
(based on that used for wine) method with chloroform extraction and reconstitution in 
binding buffer, was evaluated. As shown in Figure 22, there was clearly no 
concentration-dependent increase in fluorescent response in the assay. Measurement of 
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OTA in serum extracts (redissolved in binding buffer) suggested very little recovery by 
this technique.  
 
Figure 22: Change in fluorescent intensity upon addition of extracted BFS spiked samples. 
  
It has, in fact, been found in multiple studies, Grajewski et al. (2012); Khlifa et al. 
(2010); Malir et al. (2013), that OTA binds readily to proteins (i.e., albumin) in serum. 
Accordingly, an alternative extraction method was investigated, and specifically, a 
previously reported method, Grajewski et al. (2012), which utilizes addition of MgCl2 
and acidification (with HCl) prior to chloroform extraction. Samples were reconstituted 
in either binding buffer or methanol and analyzed for OTA by HPLC-FD to compare 
recoveries (Figure 23). Observed recovery of OTA by either binding buffer or methanol 
was, however, quite low; although, the use of methanol was more effective (12-27%) 
compared to binding buffer (1-3%) (Figure 23 and Table 4). 
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Figure 23: Comparison of serum reconstitution with OTA calibration curve  
Table 4: Recoveries of serum in methanol and binding buffer 
 
The aptamer assay was repeated with serum that was extracted (with addition of 
MgCl2 and acidification), and specifically reconstituted in methanol. A linear 
concentration-dependent increase in fluorescent response was observed (R2=0.93) over 
the relevant range of 0-20 ppb, however, calculated LOD (8.0ng/mL) and LOQ (26.8 
ng/mL) were higher than observed for wine (Figure 24). Corresponding chromatograms 
of samples in binding buffer and methanol are given in Appendix 4 (Figure 27 and 28).  
Recoveries % 50 250 500 1000
Serum Meth 12.4381 14.2197 26.8138 24.9787
Serum BB 2.40254 1.26028 2.30345 3.11586
Concentration (ng/mL)
 
51 
 
 
Figure 24: Bar graph showing increasing change in fluorescent intensity with increasing concentration, 
with calibration including dynamic range (0-20ng/mL) 
 
Discussion 
 Toward adaptation of the aptamer-based assay, previously developed in this 
research, for high-throughput analysis of OTA in relevant biological matrices, the assay 
was evaluated with respect to wine, as a relevant agricultural product, and blood serum 
(i.e., FBS), as a biomedically relevant matrix. These matrices were found to present 
multiple challenges to the proposed assay approach. Although some of these challenges 
were overcome by relatively simple extraction and other sample preparation techniques, a 
number of limitations to these methods were found.  
OTA in Wine 
Several strategies for assay-based analysis of OTA in wine were explored 
including direct introduction into assays, dilution (in assay buffer) prior to assays, 
* 
* 
* 
* 
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removal of interfering phenolics (by PVP prior to assays), and finally simplified 
extraction and recovery of OTA from wine. Direct introduction of wine did not provide a 
concentration-dependent response in the assays (Figure 14). It has been previously 
reported, Vidal et al. (2012); Mavrikou et al. (2018), that phenolics (e.g., flavonoids, 
phenolic acids) from grapes which contribute both “color” and other characteristics to the 
wine that can interfere with aptamer-based detection, and in fact, similar affinity-based 
methods (e.g., ELISA). Interference, in the current context, could include both cross-
reactivity of aptamers with phenolics, and possible overlap in the fluorescence 
excitation/emission wavelengths between phenolics and fluorophore (i.e., FAM) used in 
the assay. With respect to the latter point, anthocyanins, which are primary phenolics 
associated with wine color, absorb in the visible range (465-560nm), as well as UV range 
(265-275nm) (38), and would likely interfere with excitation/emission wavelengths used 
in the assay (i.e., 495 and 520nm, respectively). The use of PVP which has been shown to 
bind and remove phenolics was investigated as a means to reduce these interfering 
compounds; however, subsequent HPLC-FD analysis suggested little capacity to remove 
phenolics. 
Dilution of wine (in binding buffer) prior to assays did enable relatively precise 
concentration-dependent response in the assay (Figure 15). However, this approach 
requires a 100-fold dilution of wine and would likely limit the effectiveness of the assay 
with respect to environmental and biomedically relevant OTA concentrations which are 
typically in low (0-10) ppb ranges. In the case of wines, for example, the currently 
established EU regulatory limit is 2ppb.  
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Finally, extraction of OTA from wine was investigated and specifically a 
simplified LLE method previously developed for application to HPLC-FD (17). In 
addition, the suitability of recovery solvent (use to reconstitute extracts) was assessed. It 
was found that a simple LLE with chloroform was, when coupled to OTA reconstitution 
in methanol, relatively effective in the recovery of OTA from wine (Figure 19), and 
furthermore, enabled concentration-dependent fluorescent response in the aptamer assay 
(and thus, potentially quantitative application) for OTA in wine (Figure 20). However, 
sensitivity was approximately 2-fold lower, based on calculated LOD/LOQ, compared to 
results observed for OTA alone (in development of the assay; See Chapter 2). 
OTA in Serum 
 As a biomedically and forensically relevant sample application, blood serum 
(FBS) was evaluated as a sample matrix. OTA has been found in human serum in 
association with exposure to OTA via contaminated food or other agricultural products 
and in relation to asserted human health effects (e.g. nephropathy, cancer) (1), (5), (9), 
(10), (31). 
 Similar to wine, introduction of OTA-spiked FBS by both direct dilution into 
assays, and following solvent extraction, were evaluated. Direct introduction (dilution) 
into assays was clearly unable to illicit a concentration-dependent (and, therefore, 
quantitative) response in assays (Figure 21). Although a relatively simple solvent (i.e. 
LLE) based method for extraction was developed, and found to improve recovery and 
assay performance including a concentration-dependent response (Figure 24), the 
calculated LOD/LOQ suggest a highly reduced sensitivity of the assay (with a 4-fold 
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decrease, compared to OTA alone; See Chapter 2). This is likely due to the low recovery 
of OTA from serum (Figure 23 and Table 4). Indeed, previous studies have shown that 
OTA readily binds to albumin in serum and likely limits the recovery in the extraction 
and assay developed here. Future studies should focus on refinement of extraction 
techniques to overcome this limitation, and otherwise, improve sensitivity of the assay. 
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CHAPTER 5: CONCLUSION 
 
Ochratoxin A is a widespread and potent mycotoxin that contaminates a wide 
range of crop plants, and thus, foods and other agricultural products (29) (39) (40) (See 
Chapter 1). The current research focused on development of novel and sensitive aptamer-
based method for detection and quantitation of OTA in relevant sample matrices. 
Specifically, the approach developed herein utilized a fluorescence quenching of 
complementary oligonucleotide aptamers, and more specifically, adaptation of this 
approach to a high-throughput (e.g., 96-well plate) format. A solution-based aptamer 
assay showed promising results (Chapter 2) with a calculated LOD of approximately 2.7 
ng/mL and LOQ of 8.9 ng/mL which would potentially enable detection and quantitation 
in parts-per-billion concentration ranges relevant to applications for assessment of OTA 
in agricultural products, medically and/or forensically relevant samples. 
Techniques for immobilization of aptamers in multiwell plate formats were 
investigated (Chapter 3), specifically as a means to integrate sample “clean-up” (via 
“target trapping” and/or removal interfering species by washing steps). Approaches 
included the use of biotin/streptavidin binding to test plates, and SMCC-based chemistry 
for covalent binding to plates. None of the approaches provided reproducible, or even 
concentration-dependent, responses in assay upon addition of OTA. Among other 
explanations (e.g., apparent lack of effective immobilization by SMCC), it was concluded 
that limitations of fluorescence detection in assays may relate to the optical properties 
and specifically efficacy of plate readers for fluorometric measurements, of surface 
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immobilized nature of the aptamers. Future studies will need to explore this 
methodological aspect. 
Application of the aptamer-based assay was evaluated for relevant matrices 
including wine and serum (Chapter 4). It was found that extraction from either matrix 
was required. Extraction techniques that were applied did enable quantitative utility of 
the assay. However, sensitivity in both cases was lower than expected (from assay 
development studies; Chapter 2). Calculated limits of detection, and quantitation, were in 
the ppb range (i.e., LOD= 4.4 ng/mL and 8.0 ng/mL, respectively, for wine and serum), 
however, were lower (2- and 4- fold respectively, for wine and serum) than OTA alone. 
This is likely due to the relatively low recovery of OTA (> 90% and > 25% for wine and 
serum, respectively) afforded by solvent extraction and subsequent reconstitution steps. 
Recommendations for future work would include optimization of extraction and 
sample preparation methods for wine and serum (and other future applications). In 
addition, the limited potentially “optimistic” result for test formats based on immobilized 
aptamers would also suggest future value, continue investigation of this approach which 
would, likewise, potentially improve efficacy of the assay to agricultural, biomedical, 
forensic, and other (e.g., environmental) applications.  
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Appendix 1 
Name/ Purpose Fluorophore Quencher 
SOLUTION 5’- GAT CGG GTG TGG 
GTG GCG TAA AGG 
GAG CAT CGG ACA /36-
FAM/-3’ 
5’-/55-TAMK/ TGT CCG 
ATG C-3’ 
5BIOTIN/5TAMRA 5’-/5BiotinTEG/ GAT 
CGG GTG TGG GTG 
GCG TAA AGG GAG 
CAT CGG ACA /36-
FAM/-3’ 
5’-/55-TAMK/ TGT CCG 
ATG C-3’ 
3BIOTIN/ 3TAMRA 5’/56-FAM/TGA TCG 
GGT GTG GGT GGC 
GTA AAG GGA GCA 
TCG GAC A/3BioTEG/-3’ 
5’ CCC ACA CCC GAT 
T/36-TAMSp/-3’ 
Cy5/IAbRQ 5’- GAT CGG GTG TGG 
GTG GCG TAA AGG 
GAG CAT CGG ACA 
/3Cy5Sp/-3’ 
5’-/IAbRQ/ TGT CCG 
ATG C-3’ 
Cy5/IAbRQ 
BIOTINYLATED 
5’-/5BiotinTEG/ GAT 
CGG GTG TGG GTG 
GCG TAA AGG GAG 
CAT CGG ACA /3Cy5Sp/-
3’ 
5’-/IAbRQ/ TGT CCG 
ATG C-3’ 
THIOL 5’-/5ThioMC6-D/ GAT 
CGG GTG TGG GTG 
GCG TAA AGG GAG 
CAT CGG ACA /36-
FAM/-3’ 
5’-/55-TAMK/ TGT CCG 
ATG C-3’ 
MICROCYSTIN 5’- GGC GCC AAA CAG 
GAC CAC CAT GAC 
AAT TAC CCA TAC 
CAC CTC ATT ATG CCC 
CAT CTC-/36-FAM/-3’ 
5’-/55TAMK/ GCG GAG 
ATG G- 3’ 
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Appendix 2 
 
Table 5: ANOVA to determine significant differences between the percent change in fluorescent intensity 
for spiked OTA concentrations of 0, 1, 2, 5, 10, 15, and 20 ng/mL. 
 
 
Table 6: t-test difference between 0 and 1 ng/mL (left) and t-test difference between 1-5 ng/mL (right) 
   
 
t-Test: Two-Sample Assuming Equal Variances
0ppb 1ppb
Mean 6.05484 7.654094
Variance 1.786239 0.24914
Observations 5 5
Pooled Variance1.017689
Hypothesized Mean Difference0
df 8
t Stat -2.50657
P(T<=t) one-tail0.018283
t Critical one-tail1.859548
P(T<=t) two-tail0.036566
t Critical two-tail2.306004
t-Test: Two-Sample Assuming Equal Variances
1ppb 5ppb
Mean 7.654094 13.34768
Variance 0.24914 0.175141
Observations 5 5
Pooled Variance0.21214
Hypothesized Mean Difference0
df 8
t Stat -19.5454
P(T<=t) one-tail2.44E-08
t Critical one-tail1.859548
P(T<=t) two-tail4.88E-08
t Critical two-tail2.306004
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Table 7: t-test difference between 1 and 15 ng/mL (left) and t-test difference between 1 and 20ng/mL (right) 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
t-Test: Two-Sample Assuming Equal Variances
15ppb 1ppb
Mean 12.76976 7.654094
Variance 29.25187 0.24914
Observations 5 5
Pooled Variance14.7505
Hypothesized Mean Difference0
df 8
t Stat 2.10605
P(T<=t) one-tail0.034146
t Critical one-tail1.859548
P(T<=t) two-tail0.068292
t Critical two-tail2.306004
t-Test: Two-Sample Assuming Equal Variances
20ppb 1ppb
Mean 17.10864 7.654094
Variance 2.030175 0.24914
Observations 5 5
Pooled Variance1.139657
Hypothesized Mean Difference0
df 8
t Stat 14.00308
P(T<=t) one-tail3.28E-07
t Critical one-tail1.859548
P(T<=t) two-tail6.56E-07
t Critical two-tail2.306004
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Appendix 3 
 
Table 8: ANOVA to determine significant differences between the percent change in fluorescent intensity 
for various spiked OTA concentrations of 0, 1,5, 10, and 20 ng/mL for the 5BIOTIN assay. 
 
 
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance
0ppb 2 25.8528 12.9264 13.20752
1ppb 2 34.85917 17.42958 31.01861
5ppb 2 26.22408 13.11204 2.276456
10ppb 2 27.76077 13.88038 15.95848
20ppb 2 62.94928 31.47464 341.9591
ANOVA
Source of VariationSS df MS F P-value F crit
Between Groups496.4382 4 124.1096 1.534414 0.321066 5.192168
Within Groups404.4202 5 80.88403
Total 900.8584 9
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Table 9: ANOVA to determine significant differences between the percent change in fluorescent intensity 
for various spiked OTA concentrations of 0, 1,5, 10, and 20 ng/mL for the 3BIOTIN assay. 
 
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance
0PPB 2 16.66571 8.332857 6.168985
1PPB 2 16.10863 8.054316 4.607152
5PPB 2 19.63154 9.815768 0.160996
10PPB 2 25.44309 12.72155 9.580523
20PPB 2 27.08687 13.54343 7.4149
ANOVA
Source of VariationSS df MS F P-value F crit
Between Groups50.6872 4 12.6718 2.268285 0.19651 5.192168
Within Groups27.93256 5 5.586511
Total 78.61976 9
 
68 
 
Table 10: Two factor ANOVA output comparing Tris and HEPES buffer for 5BIOTIN assay 
 
 
 
 
 
 
 
 
Anova: Two-Factor With Replication
SUMMARY0PPB 0.5PPB 1PPB 2PPB 5PPB Total
Tris
Count 2 2 2 2 2 10
Sum 15.14871 15.96287 16.24895 22.35158 16.57895 86.29105
Average 7.574355 7.981435 8.124473 11.17579 8.289474 8.629105
Variance 1.55071 15.71641 0.963011 19.0507 4.124713 6.46452
HEPES
Count 2 2 2 2 2 10
Sum 19.74325 16.14522 20.13756 22.63747 19.27326 97.93676
Average 9.871623 8.072612 10.06878 11.31874 9.636628 9.793676
Variance 2.562701 17.18127 13.5098 16.09151 1.892931 6.891866
Total
Count 4 4 4 4 4
Sum 34.89196 32.10809 36.3865 44.98905 35.8522
Average 8.722989 8.027024 9.096625 11.24726 8.963051
Variance 3.130283 10.96867 6.084378 11.72088 2.610823
ANOVA
Source of VariationSS df MS F P-value F crit
Buffer 6.781122 1 6.781122 0.731957 0.412279 4.964603
Concentration23.44351 4 5.860879 0.632625 0.650574 3.47805
Interaction 4.12021 4 1.030052 0.111184 0.975748 3.47805
Within 92.64375 10 9.264375
Total 126.9886 19
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Appendix 4 
 
Table 11: t-test difference between 20 and 30 ng/mL spiked wine in solution-based assay 
 
 
 
Figure 25: Chromatogram of wine reconstituted in binding buffer  
 
 
 
t-Test: Two-Sample Assuming Equal Variances
30PPB 20PPB
Mean 24.04006 8.409634
Variance 118.9755 78.43149
Observations 2 2
Pooled Variance98.70349
Hypothesized Mean Difference0
df 2
t Stat 1.573274
P(T<=t) one-tail0.128149
t Critical one-tail2.919986
P(T<=t) two-tail0.256299
t Critical two-tail4.302653
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Figure 26: Chromatogram of wine reconstituted in methanol  
 
 
 
Figure 27: Chromatogram of serum reconstituted in binding buffer  
 
 
 
Figure 28: Chromatogram of serum reconstituted in methanol  
